You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 16, 2025

Claims for Patent: 6,106,864

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 6,106,864

Title:	Pharmaceutical formulations containing darifenacin
Abstract:	PCT No. PCT/EP96/03719 Sec. 371 Date Mar. 15, 1998 Sec. 102(e) Date Mar. 15, 1998 PCT Filed Aug. 21, 1996 PCT Pub. No. WO97/09980 PCT Pub. Date Mar. 20, 1997There is provided a pharmaceutical dosage form adapted for administration to the gastrointestinal tract of a patient, comprising darifenacin, or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable adjuvant, diluent or carrier, characterized in that the dosage form is adapted to deliver at least 10% by weight of the darifenacin, or the pharmaceutically acceptable salt thereof, to the lower gastrointestinal tract of the patient. The formulation minimizes unwanted side-effects and increases the bioavailability of darifenacin.
Inventor(s):	Thomas Francis Dolan, Michael John Humphrey, Donald John Nichols
Assignee:	Allergan Pharmaceuticals International Ltd
Application Number:	US09/029,072
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 6,106,864
Patent Claims:

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.